c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis
2020 · Cell Death and Disease · 88 citations
https://doi.org/10.1038/s41419-020-02980-2
X
Xiaoxiang Guan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
220
Papers
7.3K
Citations
44
h-index
125
i10-index
Xiaoxiang Guan is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer-related Molecular Pathways & RNA modifications and cancer & MicroRNA in disease regulation. The author has an h-index of 44, co-authored 187 publications.
ORCID: 0000-0001-6145-0046Papers by this author
worksHeterogeneity of CTC contributes to the organotropism of breast cancer
2021 · Biomedicine & Pharmacotherapy · 63 citations
https://doi.org/10.1016/j.biopha.2021.111314
Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance
2015 · Journal of Cellular and Molecular Medicine · 61 citations
https://doi.org/10.1111/jcmm.12662
DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors
2019 · Neoplasia · 52 citations
https://doi.org/10.1016/j.neo.2019.04.001
RETRACTED ARTICLE: BRCA1 inhibits AR–mediated proliferation of breast cancer cells through the activation of SIRT1
2016 · Scientific Reports · 45 citations
https://doi.org/10.1038/srep22034
Lapatinib induces p27<sup>Kip1</sup>-dependent G₁ arrest through both transcriptional and post-translational mechanisms
2013 · Cell Cycle · 37 citations
https://doi.org/10.4161/cc.25728
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat